83_FR_33007 83 FR 32871 - Meeting of the National Advisory Council for Healthcare Research and Quality

83 FR 32871 - Meeting of the National Advisory Council for Healthcare Research and Quality

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality

Federal Register Volume 83, Issue 136 (July 16, 2018)

Page Range32871-32872
FR Document2018-15105

In accordance with the Federal Advisory Committee Act, this notice announces a meeting of the National Advisory Council for Healthcare Research and Quality.

Federal Register, Volume 83 Issue 136 (Monday, July 16, 2018) 
[Federal Register Volume 83, Number 136 (Monday, July 16, 2018)]
[Notices]
[Pages 32871-32872]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-15105]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Meeting of the National Advisory Council for Healthcare Research 
and Quality

AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces a meeting of the National Advisory Council for 
Healthcare Research and Quality.

DATES: The meeting will be held on Wednesday, July 18, 2018, from 8:30 
a.m. to 2:45 p.m.

ADDRESSES: The meeting will be held at AHRQ, 5600 Fishers Lane, 
Rockville, Maryland, 20857.

FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management 
Official, at the Agency for Healthcare Research and Quality, 5600 
Fishers Lane, Mail Stop 06E37A, Rockville, Maryland 20857, (301) 427-

[[Page 32872]]

1456. For press-related information, please contact Alison Hunt at 
(301) 427-1244 or [email protected].
    If sign language interpretation or other reasonable accommodation 
for a disability is needed, please contact the Food and Drug 
Administration (FDA) Office of Equal Employment Opportunity and 
Diversity Management on (301) 827-4840, no later than Tuesday, July 3, 
2018. The agenda, roster, and minutes will be available from Ms. Bonnie 
Campbell, Committee Management Officer, Agency for Healthcare Research 
and Quality, 5600 Fishers Lane, Rockville, Maryland 20857. Ms. 
Campbell's phone number is (301) 427-1554.

SUPPLEMENTARY INFORMATION:

I. Purpose

    The National Advisory Council for Healthcare Research and Quality 
is authorized by Section 941 of the Public Health Service Act, 42 
U.S.C. 299c. In accordance with its statutory mandate, the Council is 
to advise the Secretary of the Department of Health and Human Services 
and the Director of AHRQ on matters related to AHRQ's conduct of its 
mission including providing guidance on (A) priorities for health care 
research, (B) the field of health care research including training 
needs and information dissemination on health care quality and (C) the 
role of the Agency in light of private sector activity and 
opportunities for public private partnerships. The Council is composed 
of members of the public, appointed by the Secretary, and Federal ex-
officio members specified in the authorizing legislation.

II. Agenda

    On Wednesday, July 18, 2018, the Council meeting will convene at 
8:30 a.m., with the call to order by the Council Chair and approval of 
previous Council summary notes. The meeting is open to the public and 
will be available via webcast at www.webconferences.com/ahrq com/ahrq. The 
meeting will begin with an update on AHRQ's current research, programs, 
and initiatives. The agenda will also include updates on: AHRQ Data, 
Analytics, and Insights; Making Health Services Research Relevant to 
the C-Suite; and AHRQ's Opioids efforts. The final agenda will be 
available on the AHRQ website at www.AHRQ.gov no later than Friday, 
July 13, 2018.

Francis D. Chesley, Jr.,
Acting Deputy Director.
[FR Doc. 2018-15105 Filed 7-13-18; 8:45 am]
 BILLING CODE 4160-90-P

Federal Register / Vol. 83, No. 136 / Monday, July 16, 2018 / Notices 32871 of the resolution period; and (ii) if resulting trades (or categories of resources and loss-absorbing capacity of exercising such right would trades).58 A dealer firm should assess the firm. economically benefit the counterparty the risk profile of the potential residual The discussion of strategy in the (‘‘counterparty-initiated termination’’). portfolio (including its anticipated size, public section should broadly explain • Time horizon: The duration of the composition, complexity, how the firm has addressed any resolution period should be between 12 counterparties) and the potential deficiencies, shortcomings, and other and 24 months. The resolution period counterparty and market impacts of key vulnerabilities that the Agencies begins immediately after the parent non-performance on the stability of U.S. have identified in prior Plan company bankruptcy filing and extends financial markets (e.g., on funding submissions. For each material entity, it through the completion of the preferred markets and the underlying asset should be clear how the strategy resolution strategy. markets and on clients and provides for continuity, transfer, or A dealer firm’s analysis of its counterparties). orderly wind-down of the entity and its derivatives strategy should, at a Non-surviving entity analysis. To the operations. There should also be a minimum, take into account (i) the extent the preferred resolution strategy description of the resulting organization starting profile of its derivatives assumes a material derivatives entity upon completion of the resolution portfolios (e.g., nature, concentration, enters its own resolution proceeding process. maturity, clearability, and liquidity of after the entry of the parent company The public section may note that the positions); (ii) the profile and function into a bankruptcy proceeding (a ‘‘non- resolution plan is not binding on a of the derivatives entities during the surviving material derivatives entity’’), bankruptcy court or other resolution resolution period; (iii) the means, the dealer firm should provide a authority and that the proposed failure challenges, and capacity for managing detailed analysis of how the non- scenario and associated assumptions are and de-risking its derivatives portfolios surviving material derivatives entity’s hypothetical and do not necessarily (e.g., method for timely segmenting, resolution can be accomplished within reflect an event or events to which the packaging, and selling the derivatives a reasonable period of time and in a firm is or may become subject. positions; challenges with novating less manner that substantially mitigates the By the Board of Governors of the Federal liquid positions; re-hedging strategy); risk of serious adverse effects on U.S. Reserve System, June 28, 2018. (iv) the financial and operational financial stability and to the orderly Ann E. Misback, resources required to effect the execution of the firm’s preferred derivatives strategy; and (v) any Secretary of the Board. resolution strategy. In particular, the potential residual portfolio (further firm should provide an analysis of the Dated at Washington, DC on June 28, 2018. discussed below). In addition, the firm’s potential impacts on funding markets By order of the Board of Directors. resolution plan should address the and the underlying asset markets, on Federal Deposit Insurance Corporation. following areas in the analysis of its clients and counterparties (including Valerie Jean Best, derivatives strategy: affiliates), and on the preferred Assistant Executive Secretary. Forecasts of resource needs. The resolution strategy. If the non-surviving [FR Doc. 2018–15066 Filed 7–13–18; 8:45 am] forecasts of capital and liquidity material derivatives entity is located in, BILLING CODE P resource needs required to adequately or provides more than de minimis support the firm’s derivatives strategy services to clients or counterparties should be incorporated into the firm’s located in, a non-U.S. jurisdiction, then RCEN and RLEN estimates for its overall DEPARTMENT OF HEALTH AND the analysis should also specifically HUMAN SERVICES preferred resolution strategy. These consider potential local market impacts. include, for example, the costs and/or Agency for Healthcare Research and liquidity flows resulting from (i) the VIII. PUBLIC SECTION Quality close-out of OTC derivatives, (ii) the The purpose of the public section is hedging of derivatives portfolios, (iii) to inform the public’s understanding of Meeting of the National Advisory the quantified losses that could be incur the firm’s resolution strategy and how it Council for Healthcare Research and due to basis and other risks that would works. Quality result from hedging with only exchange- The public section should discuss the traded and centrally cleared instruments steps that the firm is taking to improve AGENCY: Agency for Healthcare Research in a severely adverse stress resolvability under the U.S. Bankruptcy and Quality (AHRQ), HHS. environment, and (iv) the operational Code. The public section should ACTION: Notice of public meeting. costs. provide background information on Potential residual derivatives each material entity and should be SUMMARY: In accordance with the portfolio. A dealer firm’s resolution plan enhanced by including the firm’s Federal Advisory Committee Act, this should include a method for estimating rationale for designating material notice announces a meeting of the the composition of any potential entities. The public section should also National Advisory Council for residual derivatives portfolio discuss, at a high level, the firm’s intra- Healthcare Research and Quality. transactions remaining at the end of the group financial and operational DATES: The meeting will be held on resolution period under its preferred interconnectedness (including the types Wednesday, July 18, 2018, from 8:30 resolution strategy. The method may be of guarantees or support obligations in a.m. to 2:45 p.m. a combination of approaches (e.g., place that could impact the execution of ADDRESSES: The meeting will be held at probabilistic and deterministic) but AHRQ, 5600 Fishers Lane, Rockville, sradovich on DSK3GMQ082PROD with NOTICES the firm’s strategy). There should also be should demonstrate the dealer firm’s a high-level discussion of the liquidity Maryland, 20857. capabilities related to portfolio FOR FURTHER INFORMATION CONTACT: segmentation (discussed above). The 58 If under the firm’s preferred resolution strategy, Jaime Zimmerman, Designated dealer firm’s plan should also provide any derivatives portfolios are transferred during the Management Official, at the Agency for resolution period by way of a line of business sale detailed descriptions of the trade (or similar transaction), then those portfolios should Healthcare Research and Quality, 5600 characteristics used to identify the nonetheless be included within the firm’s potential Fishers Lane, Mail Stop 06E37A, potential residual portfolio and of the residual portfolio analysis. Rockville, Maryland 20857, (301) 427– VerDate Sep<11>2014 17:31 Jul 13, 2018 Jkt 244001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 E:\FR\FM\16JYN1.SGM 16JYN1

32872 Federal Register / Vol. 83, No. 136 / Monday, July 16, 2018 / Notices 1456. For press-related information, DEPARTMENT OF HEALTH AND growing demand for Database results for please contact Alison Hunt at (301) 427– HUMAN SERVICES the various versions of the CG–CAHPS 1244 or Alison.Hunt@ahrq.hhs.gov. Survey, including the 12-month and If sign language interpretation or other Agency for Healthcare Research and Visit versions. In May 2011, the first set reasonable accommodation for a Quality of Database results for both the 12- disability is needed, please contact the month and Visit versions was released Food and Drug Administration (FDA) Agency Information Collection through the CAHPS Database Online Office of Equal Employment Activities: Proposed Collection; Reporting System. Opportunity and Diversity Management Comment Request AHRQ developed the database for on (301) 827–4840, no later than AGENCY: Agency for Healthcare Research CAHPS CG Survey data following the Tuesday, July 3, 2018. The agenda, and Quality, HHS. CAHPS Health Plan Database as a roster, and minutes will be available model. The CAHPS Health Plan ACTION: Notice. from Ms. Bonnie Campbell, Committee Database was developed in 1998 in Management Officer, Agency for SUMMARY: This notice announces the response to requests from health plans, Healthcare Research and Quality, 5600 intention of the Agency for Healthcare purchasers, and CMS for survey data to Fishers Lane, Rockville, Maryland Research and Quality (AHRQ) to request support public reporting of health plan 20857. Ms. Campbell’s phone number is that the Office of Management and ratings, health plan accreditation and (301) 427–1554. Budget (OMB) approve the proposed quality improvement (OMB Control information collection project Number 0935–0165, expiration 5/31/ SUPPLEMENTARY INFORMATION: 2020). Demand for survey results from ‘‘Consumer Assessment of Healthcare I. Purpose Providers and Systems (CAHPS) the CG Survey has grown as well, and Clinician and Group Survey Database.’’ therefore AHRQ developed a dedicated The National Advisory Council for Clinician and Group Database to Healthcare Research and Quality is DATES: Comments on this notice must be support benchmarking, quality authorized by Section 941 of the Public received by September 14, 2018. improvement, and research (OMB Health Service Act, 42 U.S.C. 299c. In ADDRESSES: Written comments should Control Number 0935–0197, expiration accordance with its statutory mandate, be submitted to: Doris Lefkowitz, 02/28/2019). the Council is to advise the Secretary of Reports Clearance Officer, AHRQ, by The CAHPS Database contains data the Department of Health and Human email at doris.lefkowitz@AHRQ.hhs.gov. from AHRQ’s standardized CAHPS Services and the Director of AHRQ on Copies of the proposed collection plans, Surveys which provide survey measures matters related to AHRQ’s conduct of its data collection instruments, and specific of quality to health care purchasers, mission including providing guidance details on the estimated burden can be consumers, regulators, and policy on (A) priorities for health care research, obtained from the AHRQ Reports makers. The Health Plan Database also (B) the field of health care research Clearance Officer. provides data for AHRQ’s annual including training needs and FOR FURTHER INFORMATION CONTACT: National Healthcare Quality and information dissemination on health Doris Lefkowitz, AHRQ Reports Disparities Reports. care quality and (C) the role of the Clearance Officer, (301) 427–1477, or by The goal of this project is to renew the Agency in light of private sector activity emails at doris.lefkowitz@ CAHPS CG Survey Database. This and opportunities for public private AHRQ.hhs.gov. database will continue to update the partnerships. The Council is composed CAHPS CG Database with the latest SUPPLEMENTARY INFORMATION: of members of the public, appointed by results of the CAHPS CG Survey. These the Secretary, and Federal ex-officio Proposed Project results consist of 31 items that measure members specified in the authorizing 5 areas or composites of patients’ Renewal of the Consumer Assessment of legislation. experiences with physicians and staff in Healthcare Providers and Systems II. Agenda (CAHPS) Clinician and Group Survey outpatient medical practices. This Database database can be used to do the On Wednesday, July 18, 2018, the following: Council meeting will convene at 8:30 In accordance with the Paperwork (1) Improve care provided by a.m., with the call to order by the Reduction Act, 44 U.S.C. 3501–3521, individual providers, sites of care, Council Chair and approval of previous AHRQ invites the public to comment on medical groups, or provider networks. Council summary notes. The meeting is this proposed information collection. (2) Offer several products and open to the public and will be available The CAHPS Database is a repository for services, including providing survey via webcast at www.webconferences. data from selected CAHPS surveys. The results presented through an Online com/ahrq. The meeting will begin with primary purpose of the CAHPS Database Reporting System, summary chartbooks, an update on AHRQ’s current research, is to facilitate comparisons of CAHPS custom analyses, private reports in programs, and initiatives. The agenda survey results by survey users. This Excel format, and data for research will also include updates on: AHRQ voluntary compilation of survey results purposes. Data, Analytics, and Insights; Making from a large pool of data into a single (3) Provides information to help Health Services Research Relevant to database enables survey users to identify strengths and areas with the C-Suite; and AHRQ’s Opioids compare their own results to relevant potential for improvement in patient efforts. The final agenda will be Database results. The CAHPS Database care. The five composite measures are: sradovich on DSK3GMQ082PROD with NOTICES available on the AHRQ website at also offers an important source of Getting Timely Appointments, Care, and www.AHRQ.gov no later than Friday, primary data for research related to Information July 13, 2018. consumer assessments of quality as How Well Providers Communicate With measured by CAHPS surveys. Patients Francis D. Chesley, Jr., The CAHPS Clinician & Group Survey Helpful, Courteous, and Respectful Acting Deputy Director. (CG–CAHPS) Database is the newest Office Staff [FR Doc. 2018–15105 Filed 7–13–18; 8:45 am] component of the CAHPS Database. It Providers’ Use of Information to BILLING CODE 4160–90–P was developed in response to the Coordinate Patient Care VerDate Sep<11>2014 17:31 Jul 13, 2018 Jkt 244001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\16JYN1.SGM 16JYN1


Document Created: 2018-07-14 00:54:23
Document Modified: 2018-07-14 00:54:23
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of public meeting.
DatesThe meeting will be held on Wednesday, July 18, 2018, from 8:30 a.m. to 2:45 p.m.
ContactJaime Zimmerman, Designated Management Official, at the Agency for Healthcare Research and Quality, 5600 Fishers Lane, Mail Stop 06E37A, Rockville, Maryland 20857, (301) 427- 1456. For press-related information, please contact Alison Hunt at (301) 427-1244 or [email protected]
FR Citation83 FR 32871 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR